Castration refractory prostate cancer: cinderella finally comes to the ball

MeSH terms

• Androstenes
• Androstenols / adverse effects
• Androstenols / therapeutic use
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Agents, Hormonal / adverse effects
• Antineoplastic Agents, Hormonal / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Clinical Trials, Phase III as Topic
• Drug Resistance, Neoplasm
• Drugs, Investigational / adverse effects
• Drugs, Investigational / therapeutic use
• Humans
• Male
• Neoplasms, Hormone-Dependent / blood
• Neoplasms, Hormone-Dependent / drug therapy
• Neoplasms, Hormone-Dependent / surgery*
• Orchiectomy*
• Prostatic Neoplasms / blood
• Prostatic Neoplasms / drug therapy
• Prostatic Neoplasms / surgery*
• Randomized Controlled Trials as Topic
• Taxoids / adverse effects
• Taxoids / therapeutic use
• Testosterone / blood
• Tissue Extracts / adverse effects
• Tissue Extracts / therapeutic use